Evidence map›Paper›PMID 27913606›Full record

Trial reportEuropean journal of endocrinology2017

Acute administration of acyl, but not desacyl ghrelin, decreases blood pressure in healthy humans.

Cecilia J Zhang, Martin Bidlingmaier, Mekibib Altaye, Laura C Page, David D'Alessio, Matthias H Tschöp, Jenny Tong

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in European journal of endocrinology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Cardiovascular autonomic dysfunction and sleep abnormalities in children with Prader-Willi syndrome.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Physiological Effect of Ghrelin on Body Systems.International journal of endocrinology · 2020
    Review
  15. Article
  16. Ghrelin regulation of glucose metabolism.Journal of neuroendocrinology · 2019
    Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Cecilia J ZhangDivision of EndocrinologyMetabolism and Nutrition, Department of Medicine, Duke University, Durham, North Carolina, USA.
Martin BidlingmaierMedizinische Klinik und Poliklinik IVLudwig-Maximilians-Universität, Munich, Germany.
Mekibib AltayeBiostatisticsClinical Translational Research Center, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Laura C PageDivision of Pediatric Endocrinology and DiabetesDepartment of Pediatrics, Duke University, Durham, North Carolina, USA.
David D'AlessioDivision of EndocrinologyDiabetes and Metabolism, Department of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
Matthias H TschöpDivision of EndocrinologyDiabetes and Metabolism, Department of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
Jenny TongDivision of EndocrinologyDiabetes and Metabolism, Department of Medicine, University of Cincinnati, Cincinnati, Ohio, USA jenny.tong@duke.edu.
Duke University · USCincinnati Children's Hospital Medical Center · USLudwig-Maximilians-Universität München · DEUniversity of Cincinnati · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR026314 · NCRR · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E. · 2009 to 2011
$14.3M
Duke Research Training Program for PediatriciansT32HD043029 · NICHD · DUKE UNIVERSITY · PI BENJAMIN, DANIEL K. · 2002 to 2017
$3.7M
TRAINING PROGRAM IN INFLAMMATORY AND IMMUNOLOGICALT32AI007217 · NIAID · DUKE UNIVERSITY · PI PISETSKY, DAVID STEPHEN · 1985 to 2015
$3.3M
The Role of Ghrelin to Regulate Insulin Secretion in Health and Diabetes.R01DK097550 · NIDDK · UNIVERSITY OF CINCINNATI · PI TONG, JENNY · 2013 to 2017
$1.7M
The Impact of Unacylated Ghrelin on Insulin Secretion and Glucose Tolerance in HuR03DK089090 · NIDDK · UNIVERSITY OF CINCINNATI · PI TONG, JENNY · 2010 to 2011
$156k
NCRR NIH HHS UL1 RR026314NIAID NIH HHS T32 AI007217NICHD NIH HHS T32 HD043029NIDDK NIH HHS R01 DK097550NIDDK NIH HHS R03 DK089090
6 · The paper itself

Abstract

objectiveTo compare the effects of acyl ghrelin (AG) and desacyl ghrelin (DAG) on blood pressure (BP), heart rate (HR) and other autonomic parameters in healthy humans and to elucidate the hormonal mechanisms through which AG could exert its cardiovascular effects.

designSeventeen healthy participants underwent frequent monitoring of systolic (sBP) and diastolic blood pressure (dBP), HR, respiratory rate (RR) and body surface temperature (Temp) during continuous infusion of AG, DAG, combined AG + DAG or saline control before and during an IV glucose tolerance test on 4 separate days. Plasma catecholamines, renin and aldosterone levels were also measured. Differences in outcome measures between treatment groups were assessed using mixed-model analysis.

resultsCompared to the saline control, AG and combined AG + DAG infusions decreased sBP, dBP, mean arterial blood pressure (MAP), HR and Temp. In contrast, DAG infusion did not alter BP, RR or Temp, but did decrease HR. The AG and AG + DAG infusions also raised plasma aldosterone levels compared to saline (P < 0.001) without affecting renin or catecholamine levels.

conclusionsThe decrease in BP, HR, RR and Temp with AG infusion suggests mediation through the autonomic nervous system. The lack of response to DAG suggests that these autonomic effects require activation of the ghrelin receptor.

Indexed as

AcylationAdultAntihypertensive AgentsBlood PressureFemaleGhrelinHeart RateHumansHypertensionMaleMiddle AgedTemperatureTreatment OutcomeYoung AdultAntihypertensive AgentsGhrelinghrelin, des-n-octanoyl

Identifiers

PMID27913606
PMCPMC5325691
OpenAlexW2551187672

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.